1Solti F, Lengyel E, Jellinek H. Coronary arteriopathy after lymphatic blockade: an experimental study in dogs [ J ]. Lymphology, 1994, 27(4) : 158-160.
3Chumakov VIu. The architectonics of the lymphatic networks in the sheep heart [ J ]. Morfologiia, 1996,110( 5 ) : 73-75.
4Volod'ko VP, Kfivskii IL. Topography of lymphatic collectors and regional lymph nodes of the canine heart and their morphological characteristics[ J ]. Arkh Anat Gistol Embriol, 1991,1130( 1 ) :31-39.
5Miller A, Pick R, Katz L. Ventricular endomyocardial pathology produced by chronic cardiac lymphatic obstruction in the dog[ J]. Circ Res,1960,8:941-947.
6Icbihara S, Senbonmatsu T, Price E Jr. Angiotensin Ⅱ type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin Ⅱ-induced hypertension [ J]. Circulation, 2001,104 ( 3 ) :247-248.
7Manabe 1,Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertropby [ J]. Circ Res, 2002,91 ( 12 ):1103-1113.
8Lira DS. Angiotensin Ⅱ blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy [J ].Circulation,2001,103(6) :789-791.
9Sun Y, Weber KT. Angiontensin Ⅱ and aldosterone receptor binding in rat heart and kideny: response to chronic angiotensin Ⅱ or aldosterone administration [ J]. Lab Clin Med, 1993,122(4) :404-411 .
10Qin W, Rudolph AE, Bond BR. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure[J] . Circ Res, 2003,93 ( 1 ) : 69-76.
